José Aguado to Spain
This is a "connection" page, showing publications José Aguado has written about Spain.
Connection Strength
0.303
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study. Int J Infect Dis. 2021 Apr; 105:319-325.
Score: 0.059
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus. Infect Dis (Lond). 2018 Nov - Dec; 50(11-12):837-846.
Score: 0.050
-
Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study. Transpl Infect Dis. 2018 Dec; 20(6):e12988.
Score: 0.050
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients? Atherosclerosis. 2018 02; 269:204-210.
Score: 0.048
-
Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain. Emerg Infect Dis. 2017 07; 23(7):1155-1159.
Score: 0.046
-
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol. 2020 Nov; 105(5):597-607.
Score: 0.014
-
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain. Transpl Infect Dis. 2020 Oct; 22(5):e13372.
Score: 0.014
-
Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1105-1111.
Score: 0.013
-
Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. Clin Infect Dis. 2014 May; 58(10):1413-21.
Score: 0.009